Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence

NCT00563797 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Yale University

Collaborators